PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,801 stories, page 221 of 631

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Walmart raises annual targets - pharmaceutical sales weigh on US business

Fashion UnitedOriginal source
🌍Researchkemri.go.keTier 2 · Direct publisher

KEMRI Joins National Dialogue to Advance Kenya’s Universal Health Coverage Agenda

KEMRI KenyaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Creative Medical finishes treating back-pain patients who use opioids

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Michelle Britt on the Three Forces Reshaping Independent Pharmacy Economics

Pharmaceutical CommerceOriginal source
🌍Industrysubtlemedical.comTier 1 · Company source

Subtle Medical Appoints Lawrence N. Tanenbaum, MD, as Executive Medical Director

Subtle MedicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why pharmaceutical companies are interested in psychedelics

marketplace.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cockroaches in kitchen, ‘unsafe’ food storage: FDA suspends food licences of more Mumbai eateries

The HinduOriginal source
🇮🇪CROiconplc.comTier 2 · Direct publisher

ICON releases 2025 ICON Cares Report

ICON plcOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regeneron to challenge Ipsen as FDA clears bone disease drug

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Realcan Pharmaceutical Group's Board Elects Chairman

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Insilico Medicine announces ARDD 2026 program, bringing global leaders in longevity biotechnology to Boston

EurekAlert!Original source
🌍discoverynews.google.comTier 3 · Aggregated media

VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX C001 in urgent surgery

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI & bioweapons: Harvard's Elizabeth Sherwood-Randall on navigating the AI-biotech era

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cantor Fitzgerald Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump Picks Dr. Heidi Overton, a Top White House Aide, to Lead the Food and Drug Administration

Morning Ag ClipsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ask the Expert: Complying with Standards

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for Cannabis Withdrawal in Patients with Cannabis Use Disorder

PR NewswireOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Theragun PRO

The charger of the Theragun G4PRO massage device can overheat while charging the device's removable...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Patient Information Centre iX

Philips received reports that some PIC iX systems were frozen and could not be used. It was determin...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Centricity™ Enterprise Archive and PACS Workstation

GE Healthcare has become aware that, under certain conditions, historical imaging data migrated from...

Health Canada Recalls and Safety AlertsOriginal source
🇺🇸CROir.criver.comTier 2 · Direct publisher

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

Charles River LaboratoriesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EVAXION BIOTECH ($EVAX) Releases Q2 2026 Earnings

Quiver QuantitativeOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Dynamics of the Icelandic Ice Sheet Altered the Chemistry of North Atlantic Seawater

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Evaxion Biotech: Q2 2026 featured pipeline advances, a $3.7M net loss, and cash runway into H2 2027

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hammer toe has no FDA-approved nonsurgical therapy. Keenova doses the first patient in Phase 3.

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Silicone Tubing for Biotech Market Growth to 2035 Driven by Single-Use Systems - News and Statistics

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (NASDAQ:BMRN) Raised to "Strong-Buy" at BMO Capital Markets

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Donald Trump Nominates Dr. Heidi Overton to Lead the U.S. Food and Drug Administration: how 22 outlets framed it

NewsCordOriginal source
🇺🇸Industrytechcyte.comTier 1 · Company source

Techcyte Reorganizes Board of Directors to Support Next Phase of Growth

TechcyteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (CANC) Hits New 52-Week High

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DMD Biotech Delivers Early Muscle Data as SAT-3247 Advances

Streetwise ReportsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sarepta Therapeutics Delivers Q2 Operating Profit as CEO Transition Advances Pipeline

Streetwise ReportsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TD Cowen raises Helus Pharma stock price target to $62 on trial timing

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Kynexis pockets €97m to advance cognition-focused schizophrenia drug

Pharmaceutical TechnologyOriginal source
🌍Mediasaama.comTier 2 · Direct publisher

Why Metadata Reuse Breaks at Scale in Global Study Builds

SaamaOriginal source
🇩🇪Researchuni-freiburg.deTier 2 · Direct publisher

Rector’s Annual Report for 2025 has been published

University of FreiburgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical industry priorities for the Health Data Research Service

The Association of the British Pharmaceutical Industry|ABPIOriginal source
🌍discoverynews.google.comTier 2 · Trade media

One of the most consequential years for cancer treatment, ever

STATOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Italy's $10 Billion Angelini Family Bets $4.1 Billion In U.S. Biotech

ForbesOriginal source
🌍Researchkemri.go.keTier 2 · Direct publisher

KEMRI becomes the first African Institute to Join the Global Dengue Alliance

KEMRI KenyaOriginal source
🇪🇺Associationeucope.orgTier 2 · Direct publisher

Global Pharma & Biotech Summit (10-11 November 2026)

EUCOPEOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech Stock Sinks After Fresh Capital Raise

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lab 4.0 balance: connected, compliant and ready to integrate

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Non-Profit Pharmaceutical Manufacturer Delivers Drug Access to Rural Hospitals

The Daily YonderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA proposes mandatory GRAS notifications in major overhaul of ingredient framework

Aquafeed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ExpreS2ion Biotech: Strong clinical and financial momentum in Q2 2026, with ES2B-C001 advancing and cash bolstered

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UBS upgrades Sartorius Stedim Biotech to Buy

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical production compliance burdens nobody talks about

Cleanroom TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical production compliance burdens nobody talks about

Cleanroom TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mankind Pharma licenses two Chinese insulin analogues for India

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

White House aide nominated for FDA commissioner role

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong Stocks Rise as mRNA Vaccine Breakthrough Sparks Biotech Frenzy

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Generation Investment Management LLP Invests $728.17 Million in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source